EU Clearance Unlocks €18m Boost for Novel Mycoprotein

EU clearance unlocks €18m boost for novel mycoprotein

The Protein Brewery raises €18m after EU approval for its mycoprotein Fermotein, signalling growth for fermentation-based protein in Europe.

The Protein Brewery Adds $20.5M to Series B Funding for Mycoprotein Launch

4 Mins Read Dutch food tech startup The Protein Brewery has closed an €18M ($20.5M) extension of its Series B round to expand production of its Fermotein mycoprotein and support its EU launch. Days after securing the first novel food approval for whole-food mycelium protein in the EU, The Protein Brewery has raised €18M ($20.5M) in a Series B extension round. The Dutch fermentation specialist is building on the €30M ($35M at the time) Series B f…

The Protein Brewery raises €48.2M in Series B funding, sets sights on active nutrition and longevity

The Protein Brewery has added a further €18 million to its Series B funding round as it gears up to scale production capacity, drive sales in active nutrition, and advance research into the longevity benefits of its flagship mycoprotein ingredient, Fermotein.

The Protein Brewery closes €18m Series B extension following landmark EU novel food approval

Dutch food-tech company The Protein Brewery has announced an €18 million extension of its Series B funding round, led by ABN AMRO Sustainable Impact Fund.

The Protein Brewery says FDA GRAS setback won’t derail US plans as it raises $20.5m Series B extension

The Protein Brewery—which has just secured the green light to market its novel mycelium ingredient in the EU—has been advised by the FDA to withdraw its GRAS notice in the US due to deficiencies in its application. However, CEO Thijs Bosch tells AgFunderNews the temporary setback will not derail its US plans as it raises an €18 million ($20.5 million) Series B extension. The Dutch startup, which makes mycoprotein via biomass fermentation from Rh…